| Literature DB >> 23830653 |
Yoav Keynan1, Ethan Rubinstein.
Abstract
Staphylococcus aureus and methicillin-resistant S aureus have emerged as the most important nosocomial pathogens. Traditional therapy may be sufficient in most but not all patients, in whom alternatives should be sought. The infection is often complicated with several sites of metastatic foci and is nosocomial frequently. New antibiotics to fight MRSA have been introduced and are equivalent or better than vancomycin.Entities:
Keywords: Antibiotics; HAP; Infection; Linezolid; MRSA; MSSA; Staphylococcus aureus; Treatment; VAP; Vancomycin
Mesh:
Substances:
Year: 2013 PMID: 23830653 DOI: 10.1016/j.ccc.2013.03.008
Source DB: PubMed Journal: Crit Care Clin ISSN: 0749-0704 Impact factor: 3.598